Establishes an awareness campaign on the use of hormone replacement therapy in treating the symptoms of perimenopause and menopause

S 1720 would have required New York's public health department to launch an awareness campaign about hormone replacement therapy (HRT) for perimenopause and menopause symptoms. The campaign would have provided women directly affected by these symptoms with plain-language information on HRT benefits, risks, side effects, available types, and current medical recommendations. The bill specifically mandated that the campaign cover symptom management, health risks, and evidence-based usage guidelines for HRT. However, the bill was vetoed by the governor on October 16, 2025, so it did not become law.